DK2495251T3 - Hydrochloridsalte af et glycopeptidphosphonatderivat - Google Patents

Hydrochloridsalte af et glycopeptidphosphonatderivat

Info

Publication number
DK2495251T3
DK2495251T3 DK12169694.2T DK12169694T DK2495251T3 DK 2495251 T3 DK2495251 T3 DK 2495251T3 DK 12169694 T DK12169694 T DK 12169694T DK 2495251 T3 DK2495251 T3 DK 2495251T3
Authority
DK
Denmark
Prior art keywords
hydrochloride salts
phosphonate derivative
glycopeptide phosphonate
glycopeptide
derivative
Prior art date
Application number
DK12169694.2T
Other languages
English (en)
Inventor
Jyanwei Liu
Junning Lee
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Application granted granted Critical
Publication of DK2495251T3 publication Critical patent/DK2495251T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK12169694.2T 2003-10-22 2004-10-21 Hydrochloridsalte af et glycopeptidphosphonatderivat DK2495251T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51335903P 2003-10-22 2003-10-22
EP04796022A EP1678201B1 (en) 2003-10-22 2004-10-21 Hydrochloride salts of a glycopeptide phosphonate derivative

Publications (1)

Publication Number Publication Date
DK2495251T3 true DK2495251T3 (da) 2014-07-07

Family

ID=34549267

Family Applications (2)

Application Number Title Priority Date Filing Date
DK04796022.4T DK1678201T3 (da) 2003-10-22 2004-10-21 Hydrochloridsalte af et glycopeptidphosphonatderivat
DK12169694.2T DK2495251T3 (da) 2003-10-22 2004-10-21 Hydrochloridsalte af et glycopeptidphosphonatderivat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK04796022.4T DK1678201T3 (da) 2003-10-22 2004-10-21 Hydrochloridsalte af et glycopeptidphosphonatderivat

Country Status (17)

Country Link
US (2) US7531623B2 (da)
EP (2) EP1678201B1 (da)
JP (2) JP4669478B2 (da)
KR (2) KR20120037025A (da)
CN (1) CN100417661C (da)
AU (1) AU2004285924B2 (da)
BR (1) BRPI0415853B8 (da)
CA (2) CA2726967A1 (da)
DK (2) DK1678201T3 (da)
ES (2) ES2477268T3 (da)
HU (1) HUE026769T2 (da)
MX (1) MXPA06004336A (da)
PL (2) PL2495251T3 (da)
PT (2) PT1678201E (da)
SI (2) SI2495251T1 (da)
TW (1) TWI342312B (da)
WO (1) WO2005042568A2 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI342312B (en) * 2003-10-22 2011-05-21 Theravance Inc Hydrochloride salts of a glycopeptide phosphonate derivative
US9233125B2 (en) 2010-12-14 2016-01-12 University Of Maryland, Baltimore Universal anti-tag chimeric antigen receptor-expressing T cells and methods of treating cancer
LT2968446T (lt) * 2013-03-13 2017-07-25 Theravance Biopharma Antibiotics Ip, Llc Antibiotinių junginių hidrochlorido druskos
KR20170123650A (ko) * 2015-02-23 2017-11-08 세라밴스 바이오파마 안티바이오틱스 아이피, 엘엘씨 텔라반신을 투여하는 투여량 및 방법
CN104877014B (zh) * 2015-06-02 2018-05-11 宁夏泰瑞制药股份有限公司 一种纯化特拉万星粗品的方法
CN106631902A (zh) * 2016-09-23 2017-05-10 上海步越化工科技有限公司 一种特拉万星侧链癸基(2‑氧代乙基)氨基甲酸9h‑芴‑9‑甲基酯的制备方法
IL270685B (en) * 2017-05-22 2022-09-01 Insmed Inc Cleavable derivatives of lipoglycopeptide and their uses
CN107629115B (zh) * 2017-09-08 2021-05-07 福建省微生物研究所 一种特拉万星的纯化方法
CN107629116B (zh) * 2017-09-08 2021-05-07 福建省微生物研究所 一种特拉万星的纯化方法
CN110824079B (zh) * 2019-11-27 2021-04-13 苏州赛分科技有限公司 特拉万星的纯化方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3067099A (en) * 1955-09-16 1962-12-04 Lilly Co Eli Vancomycin and method for its preparation
US4885275A (en) * 1987-10-15 1989-12-05 Eli Lilly And Company Vancomycin-HCL solutions and the lyophilization thereof
EP1025852A4 (en) * 1997-10-03 2001-11-07 Fujisawa Pharmaceutical Co VANCOMYCIN ANTIBIOTIC HYDROCHLORIDES AND METHOD FOR THE PRODUCTION THEREOF
CA2726789A1 (en) * 2000-02-05 2001-11-08 Theravance, Inc. Cyclodextrin containing glycopeptide antibiotic compositions
UA75083C2 (uk) * 2000-06-22 2006-03-15 Тераванс, Інк. Похідні глікопептидфосфонатів
TWI275594B (en) * 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
TWI312785B (en) * 2001-08-24 2009-08-01 Theravance Inc Process for preparing vancomycin derivatives
TWI233932B (en) * 2001-08-24 2005-06-11 Theravance Inc Process for purifying glycopeptide phosphonate derivatives
TWI342312B (en) * 2003-10-22 2011-05-21 Theravance Inc Hydrochloride salts of a glycopeptide phosphonate derivative

Also Published As

Publication number Publication date
CA2726967A1 (en) 2005-05-12
PL2495251T3 (pl) 2014-09-30
ES2400483T3 (es) 2013-04-10
AU2004285924B2 (en) 2011-02-24
ES2477268T3 (es) 2014-07-16
BRPI0415853A (pt) 2007-01-02
US20050113561A1 (en) 2005-05-26
US20090069534A1 (en) 2009-03-12
PT1678201E (pt) 2013-03-05
EP2495251A1 (en) 2012-09-05
HK1171030A1 (en) 2013-03-15
JP4669478B2 (ja) 2011-04-13
PL1678201T3 (pl) 2013-05-31
KR20060094082A (ko) 2006-08-28
BRPI0415853B8 (pt) 2021-05-25
AU2004285924A1 (en) 2005-05-12
MXPA06004336A (es) 2006-06-27
HUE026769T2 (hu) 2016-07-28
EP1678201B1 (en) 2012-12-05
US8003755B2 (en) 2011-08-23
TWI342312B (en) 2011-05-21
BRPI0415853B1 (pt) 2017-12-12
EP2495251B1 (en) 2014-04-16
TW200528473A (en) 2005-09-01
US7531623B2 (en) 2009-05-12
DK1678201T3 (da) 2013-03-04
WO2005042568A2 (en) 2005-05-12
CA2543009A1 (en) 2005-05-12
CA2543009C (en) 2011-01-11
JP2011016820A (ja) 2011-01-27
SI2495251T1 (sl) 2014-07-31
WO2005042568A3 (en) 2005-09-15
CN100417661C (zh) 2008-09-10
KR20120037025A (ko) 2012-04-18
SI1678201T1 (sl) 2013-03-29
CN1871253A (zh) 2006-11-29
PT2495251E (pt) 2014-07-11
EP1678201A2 (en) 2006-07-12
KR101166250B1 (ko) 2012-07-17
JP2007534630A (ja) 2007-11-29
HK1093516A1 (en) 2007-03-02

Similar Documents

Publication Publication Date Title
NO2021052I1 (no) relugolix or a salt thereof
IS8509A (is) Ný 2-heteróarýl-setin bensímídasól afleiða
DE60122516D1 (de) Phosphonatderivate eines glykopeptides
DK2363114T3 (da) Opretholdt afgivelse af anti-infektionsmidler
EP1663235A4 (en) CAPTURED PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS
DK1962817T3 (da) Transdermal tilførsel af et salt af meptazinol
IS8450A (is) Amíðafleiður
DK1575565T3 (da) Tablet med modificeret frigivelse af bupropion-hydrochlorid
EP1610167A4 (en) LENS WITH PROGRESSIVE BREAKING POWER
DK1657996T3 (da) Fremgangsmåde til fremstilling af en madraskerne
DK1603478T3 (da) Automatisering af et dentalmiljö
DK2495251T3 (da) Hydrochloridsalte af et glycopeptidphosphonatderivat
DK1487840T3 (da) Krystallinsk polymorf form af irinotecan hydrochlorid
DK1414824T3 (da) Nye antikonvulsive derivatsalte
NO20055612D0 (no) Anti-inflammatoriske fosfonatforbindelser
DK1667975T3 (da) En polymorf form for 3-phenylsulfonyl-8-piperazin-1-yl-quinolin
IS7598A (is) Ný sölt
DK1670785T3 (da) Salte og polymorphe former af en pyrrolsubstitueret indolinonforbindelse
DK1305312T3 (da) Tartratsalte af thiazolidindionderivat
NO20053673D0 (no) Nye antikonvulsanderivatsalter
NO20055097D0 (no) Krystallinske N-formyl-hydroksylaminforbindelser
HK1171030B (en) Hydrochloride salts of a glycopeptide phosphonate derivative
DK1305311T3 (da) Tartratsalt af thiazolidindionderivat
NO20054532D0 (no) Fremgangsmater for a forhindre glukonoylering av proteiner
ITMI20032550A1 (it) Mescole elastomeriche a base di nerofumo